Although none of the five studies examined the appearance of leukemic cells or changes to the number of remaining blasts in peripheral blood depending on the G-CSF stimulation, G-CSF prophylaxis against neutropenia may be beneficial for specific patients (e.g., with severe infections, the unfit, or elderly). The gene discussed is CSF3; the disease is Decreased total neutrophil count.